Shi Si-Feng, Dong Yang, Zhang Chun-Lin, Bao Kun, Ma Xiao-Jun
Department of Orthopaedics, Sixth People's Hospital, Shanghai Jiaotong University, Shanghai 200233, People's Republic of China.
Chin J Cancer. 2010 Jan;29(1):121-4. doi: 10.5732/cjc.009.10287.
After chemotherapy was used to treat patients with malignant bone tumors in 1970s, amputation, which was the typical intervention in the 1980s, has been substituted with limb-sparing surgery. This article reported the surgical indications, operative methods, operative effects, and complications of prosthetic replacement of the proximal humerus after the resection of bone tumors.
From April 2004 and December 2008, prosthetic replacement was performed in 18 patients with proximal humerus tumors, including 7 patients with osteosarcoma, 5 patients with chondrosarcoma, 3 patients with giant cell tumor (GCT) of the bone, 1 patient with GCT of the bone combined with an aneurysmal bone cyst, and 1 patient with metastatic bone tumors. Using the Enneking staging system, 7 osteosarcomas and 3 chondrosarcomas were at stage Ib, and 3 GCTs and 2 chondrosarcomas were at stage Ib. The patient with metastatic bone tumors reported severe pain.
The follow-up ranged 5-61 months (mean, 29 months) and showed that 1 patient with osteosarcoma died 19 months after surgery. Local recurrence presented in 1 patient with GCT, 1 patient had inner infection in the area of surgery, and 2 patients had shoulder subluxation after the operation. There was no prosthetic loosening in any patient. The abduction angle of the shoulder was 8 degrees-35 degrees, and circumgyrate angle was 18 degrees-25 degrees, with flexion 35 degrees-90 degrees and extension 25 degrees-42 degrees. According to the functional score developed by the International Society of Limb Salvage, scores ranged between 18 and 29 points, with an average of 24 points.
The prosthesis replacement for the patients with bone tumors in the proximal humerus is an appropriate procedure with satisfactory therapeutic outcomes; however, many complications should be noted and long-term therapeutic effect needs further investigations.
自20世纪70年代化疗用于治疗恶性骨肿瘤患者后,20世纪80年代典型的干预手段截肢术已被保肢手术所取代。本文报道了骨肿瘤切除术后人工肱骨头置换的手术适应证、手术方法、手术效果及并发症。
2004年4月至2008年12月,对18例肱骨近端肿瘤患者行人工肱骨头置换术,其中骨肉瘤7例,软骨肉瘤5例,骨巨细胞瘤3例,骨巨细胞瘤合并动脉瘤样骨囊肿1例,骨转移瘤1例。采用Enneking分期系统,7例骨肉瘤和3例软骨肉瘤为Ib期,3例骨巨细胞瘤和2例软骨肉瘤为Ib期。骨转移瘤患者疼痛严重。
随访时间5 - 61个月(平均29个月),1例骨肉瘤患者术后19个月死亡。1例骨巨细胞瘤患者出现局部复发,1例患者手术区域发生深部感染,2例患者术后出现肩关节半脱位。所有患者均未出现假体松动。肩关节外展角度为8° - 35°,旋转角度为18° - 25°,前屈35° - 90°,后伸25° - 42°。根据国际保肢协会制定的功能评分标准,评分在18 - 29分之间,平均24分。
肱骨近端骨肿瘤患者行人工肱骨头置换术是一种合适的手术方法,治疗效果满意;然而,应注意许多并发症,长期治疗效果有待进一步研究。